Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Czechia Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20061
20072
20091
20101
20113
20124
20133
20146
20151
20161
20172
20183
20194
20201
20214
20226
20231
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting11
Recruiting9
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Eli Lilly and Company7
Pfizer4
Sanofi4
AbbVie3
Novartis Pharmaceuticals3
Amgen2
Celcuity Inc2
AVEO Pharmaceuticals, Inc.1
Astellas Pharma Europe Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis54
Neoplasms11
Breast Neoplasms10
Carcinoma, Non-Small-Cell Lung10
Melanoma5
Prostatic Neoplasms5
Carcinoma4
Colorectal Neoplasms4
Carcinoma, Renal Cell3
Skin Diseases3

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.